Kevin O'Connell

Senior Vice President, B.Next / Life Sciences

2022 - Current

At IQT, I co-lead our group that provides thought leadership, and conducts diligence and provides oversight for our investments in health and life sciences. I have also led work in novel materials and other WMD sensors. Occasional convener, podcaster and blogger. In-Q-Tel is the not-for-profit, strategic investment firm that works to identify, adapt, and deliver innovative technology solutions to support the missions of the U.S. Intelligence Community. Launched in 1999 as a private, independent organization, IQT’s mission is to identify and partner with companies developing cutting-edge technologies that serve the national security interests of the United States.

Vice President

2010 - 2022

Senior Solutions Architect

2009 - 2010

Visionary Solutions Architect

2007 - 2009

Research Microbiologist

2000 - 2007

Research Associate

1998 - 2000

Research Associateship tenured at the US Army Edgewood Chemical Biological Center, in collaboration with the Univ. of Maryland School of Medicine. Research focused on biosensor design, recombinant antibody cloning and applications.

Research Associate

1993 - 1998

Postdoctoral fellow at the NSF Center for Microbial Ecology. Identified, cloned, sequenced, and studied the expression of cold shock genes in the gram-negative soil bacterium Sinorhizobium meliloti.